Drinking alcohol raises the risk of cancer by damaging DNA
A recent study by the Medical Research Council (MRC) Laboratory [...]
Cabozantinib more effective than everolimus for treatment of kidney cancer bone metastases
Cabozantinib (Cabometyx) was more effective than everolimus (Afinitor) in people [...]
Crizotinib shows promise in type 1 papillary kidney cancer
Papillary kidney cancer is a rare subtype of renal cell [...]
Lenvatinib plus pembrolizumab combination designated a breakthrough therapy by the FDA
The US Food and Drug Administration (FDA) have granted Breakthrough [...]
Sequencing of treatments for advanced kidney cancer remains uncertain
There are now a number of licensed drug options available [...]
Post-nephrectomy diet to reduce the risk of kidney disease
Recent studies have suggested that nephrectomy, either for kidney donation [...]
Scientists discover the mechanism for resistance to immunotherapy treatment
Scientists from the Dana-Farber Cancer Institute in Boston, USA, have [...]
Missed appointments are costing the NHS £1 billion per year
An article in The Times reports that NHS England health [...]
Improved cancer care results in over 2,000 more people surviving cancer in 2017
An NHS England press release, published on Christmas Eve, reports [...]
A new class of anti-cancer drug for kidney cancer shows promise
Researchers in America are looking at a new class of [...]
